Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization

[1] Lo CM(2002)Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164-1171

[2] Ngan H(2002)Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734-1739

[3] Tso WK(2016)Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data Hepatology 64 106-116

[4] Llovet JM(2009)Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography AJR Am J Roentgenol 192 1057-1063

[5] Real MI(2011)C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma AJR Am J Roentgenol 197 W337-W342

[6] Montaña X(2010)Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot study Cardiovasc Interv Radiol 33 1235-1242

[7] Lencioni R(2013)Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization J Vasc Interv Radiol 24 501-508

[8] de Baere T(2017)The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis J Vasc Interv Radiol 28 334-341

[9] Soulen MC(2019)Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization Clin Mol Hepatol 25 74-85

[10] Rilling WS(2012)Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma Eur J Radiol 81 3985-3992

[1] Lo CM(2002)Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164-1171

[2] Ngan H(2002)Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734-1739

[3] Tso WK(2016)Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data Hepatology 64 106-116

[4] Llovet JM(2009)Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography AJR Am J Roentgenol 192 1057-1063

[5] Real MI(2011)C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma AJR Am J Roentgenol 197 W337-W342

[6] Montaña X(2010)Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot study Cardiovasc Interv Radiol 33 1235-1242

[7] Lencioni R(2013)Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization J Vasc Interv Radiol 24 501-508

[8] de Baere T(2017)The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis J Vasc Interv Radiol 28 334-341

[9] Soulen MC(2019)Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization Clin Mol Hepatol 25 74-85

[10] Rilling WS(2012)Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma Eur J Radiol 81 3985-3992